{
  "industry-news": [
    {
        "id": "2021-10-27-nanobodies-next-gen",
        "title": "Nanobodies: The Next Generation of Antibody Therapeutics",
        "date": "2021-10-27",
        "category": "industry-news",
        "tags": ["Nanobodies", "Ablynx", "Sanofi", "VHH", "COVID-19"],
        "summary": "Discovered by accident in camel serum, Nanobodies are a unique class of antibodies. This article explores their structural advantages over IgG, manufacturing benefits, and applications in cancer and COVID-19 treatment.",
        "readTime": "6 min read",
        "filename": "2021-10-27-nanobodies-next-gen.html"
    },
    {
        "id": "2024-09-30-antibody-drug-applications",
        "title": "Beyond IgG: Different types of antibody drugs for cancer treatments",
        "date": "2024-09-30",
        "category": "industry-news",
        "tags": ["ADC", "Bispecific Antibody", "Nanobodies", "PROTAC", "molecular glue", "DAC", "RAC", "AOC", "ACC"],
        "summary": "From Bi-specifics and ADCs to newer technologies like DACs (Degrader-Antibody Conjugates) and ACC (Antibody-Cell Conjugation), this article summarizes the diverse landscape of antibody therapeutics.",
        "readTime": "8 min read",
        "filename": "2024-09-30-antibody-drug-applications.html"
    },
    {
      "id": "2026-01-13-JPM-2026-dealmaking-forecast",
      "title": "2026 JPM: Biopharma Deal-Making Forecast: Trends in M&A, AI, and Innovation",
      "date": "2026-01-13",
      "category": "industry-news",
      "tags": ["JPM2026", "M&A", "Curative Therapies", "China", "AI", "Amgen", "Merck", "AbbVie"],
      "summary": "Highlights from the J.P. Morgan Healthcare Conference panel on 2026 deal-making trends, covering M&A strategies, the rise of China and AI in innovation, and the shift towards curative therapies.",
      "readTime": "8 min read",
      "filename": "2026-01-13-JPM-2026-dealmaking-forecast.html"
    },
    {
      "id": "2026-01-15-JPM-2026-novo-nordisk-ceo-insights",
      "title": "2026 JPM: Key Insights from Novo Nordisk's CEO on the Future of Pharma",
      "date": "2026-01-15",
      "category": "industry-news",
      "tags": ["Novo Nordisk", "JPM2026", "Obesity", "Wegovy", "Acquisition", "Mike Doustdar", "compounders"],
      "summary": "Novo Nordisk CEO Mike Doustdar shares insights on disciplined M&A strategy, the consumerization of the obesity market, and the shift towards patient-paid healthcare models.",
      "readTime": "7 min read",
      "filename": "2026-01-15-JPM-2026-novo-nordisk-ceo-insights.html"
    },
    {
      "id": "2026-02-12-nobel-laureate-fred-ramsdell-insights",
      "title": "Insights from Nobel Laureate Dr. Fred Ramsdell - Communication, Fit for Purpose, and the Biotech Industry",
      "date": "2026-02-12",
      "category": "industry-news",
      "tags": ["Fred Ramsdell", "Nobel Prize", "JPM2026", "Tregs", "Biotech Industry", "Science Communication"],
      "summary": "Nobel Laureate Dr. Fred Ramsdell discusses the critical need for better science communication, the 'fit for purpose' research approach, and the parallels between early monoclonal antibodies and today's cell therapies.",
      "readTime": "6 min read",
      "filename": "2026-02-12-Nobel-Laureate-Fred-Ramsdell-insights.html"
    }
  ],
  "biotech-companies": [
        {
        "id": "2025-12-14-PeptiDream",
        "title": "PeptiDream — A Japanese Biotech Company Specializing in Next-Generation PDCs",
        "date": "2025-12-14",
        "category": "biotech-companies",
        "tags": ["Japan Biotech", "Peptidream", "Macrocyclic Peptides", "Oncology"],
        "summary": "PeptiDream is a Japanese biotech company famous for its RaPID platform. They specialize in macrocyclic peptides to target proteins that are difficult for traditional antibodies or small molecules.",
        "readTime": "10 min read",
        "filename": "2025-12-14-PeptiDream.html" 
        },
        {
      "id": "2025-06-30-eli-lilly-overview",
      "title": "Eli Lilly and Company (LLY): Corporate Overview, Pipeline, and Financial Analysis",
      "date": "2025-06-30",
      "category": "biotech-companies",
      "tags": ["Eli Lilly", "Mounjaro", "Zepbound", "Obesity", "Alzheimer's", "Financial Analysis"],
      "summary": "A deep dive into Eli Lilly's century-long history, its dominance in the GLP-1 market with Mounjaro and Zepbound, and its strategic pipeline expansion into oncology and genetic medicine.",
      "readTime": "12 min read",
      "filename": "2025-06-30-eli-lilly-overview"
    }
  ],
  "diseases": [
        {
      "id": "2025-12-08-dengue-fever",
      "title": "Dengue Fever: History, Virology, and Clinical Management",
      "date": "2025-12-08",
      "category": "diseases",
      "tags": ["Dengue Virus", "Virology", "Vaccines", "Takeda", "Sanofi", "Dengue Fever"],
      "summary": "An overview of Dengue Fever, covering the history of its first isolation by Susumu Hotta, viral structure, clinical presentation, and the current landscape of vaccines like Qdenga and Dengvaxia.",
      "readTime": "8 min read",
      "filename": "2025-12-08-dengue-fever.html"
    },
    {
      "id": "2025-12-13-menopause-vms-treatments",
      "title": "Menopause VMS and the Era of Non-Hormonal Treatments",
      "date": "2025-12-13",
      "category": "diseases",
      "tags": ["Menopause", "VMS", "KNDy Neurons", "Neurokinin B (NKB)", "Fezolinetant", "Elinzanetant", "Menopausal Hormone Therapy"],
      "summary": "An overview of the pathophysiology of menopausal vasomotor symptoms (VMS), the role of KNDy neurons, and the latest non-hormonal treatments including Fezolinetant and the newly approved Elinzanetant.",
      "readTime": "6 min read",
      "filename": "2025-12-13-menopause-vms-treatments.html"
    },
    {
      "id": "2026-01-18-adhd-mechanism-treatments",
      "title": "ADHD: Mechanisms, Standard Treatments, and the 2026 Pipeline",
      "date": "2026-01-18",
      "category": "diseases",
      "tags": ["ADHD", "Dopamine", "Norepinephrine", "Stimulants", "Methylphenidates", "Amphetamines", "Ritalin", "Adderall", "Selective Norepinephrine Reuptake Inhibitor (SNRI)", "α2A Adrenergic Receptor Agonist", "Serotonin-Norepinephrine Modulating Agent (SNMA)", "Centanafadine", "Dopamine & Norepinephrine Reuptake Inhibitor (DNRI)", "Serotonin-Norepinephrine-Dopamine Reuptake Inhibitor (SNDRI)"],
      "summary": "A comprehensive review of ADHD pathophysiology, standard of care (Stimulants vs Non-Stimulants), and the next generation of drugs including Centanafadine and Orexin agonists.",
      "readTime": "10 min read",
      "filename": "2026-01-18-adhd-mechanism-treatments.html"
    }
  ],
  "wetlab": [
    {
      "id": "2026-01-16-agar-vs-agarose",
      "title": "Agar vs. Agarose: Are they interchangeable?",
      "date": "2026-01-16",
      "category": "wetlab",
      "tags": ["Agar", "Agarose", "Molecular Biology", "Electrophoresis"],
      "summary": "We use both in the lab, but do you know the chemical difference? A look at composition, cost, and why we don't use agar for DNA gels (usually), plus some funny lab anecdotes.",
      "readTime": "5 min read",
      "filename": "2026-01-16-agar-vs-agarose.html"
    }
  ],
  "data-analysis": [
    {
      "id": "2022-11-05-youtube-index",
      "title": "YouTube Data Analysis and Visualization",
      "date": "2022-11-05",
      "category": "data-analysis",
      "tags": ["YouTube", "R", "data analysis"],
      "summary": "This is the index page for the YouTube Data Analytics series. It introduces the motivation behind the project, details the dataset used, and provides links to the other analysis articles in the series.",
      "readTime": "3 min read",
      "filename": "2022-11-05-youtube-index.html"
    },
    {
      "id": "2022-10-16-yt-us-trending",
      "title": "YouTube trending video data (1) - US",
      "date": "2022-10-16",
      "category": "data-analysis",
      "tags": ["YouTube", "R", "Kaggle", "Data Analysis"],
      "summary": "Analyzing trending YouTube videos in the US from 2020-2022 using R. Investigating top channels, categories, and revenue estimates.",
      "readTime": "10 min read",
      "filename": "2022-10-16-YT-US-trending.html"
    },
{
        "id": "2022-10-20-yt-ca-trending",
        "title": "YouTube trending video data (2) - Canada",
        "date": "2022-10-20",
        "category": "data-analysis",
        "tags": ["YouTube", "R", "Kaggle", "Data Analysis"],
        "summary": "Following the US analysis, this post explores YouTube trending videos in Canada from 2020 to 2022, analyzing popular categories, channels, and estimated ad revenue.",
        "readTime": "10 min read",
        "filename": "2022-10-20-YT-CA-trending.html"
}
  ]
}
